Acquiring an established orthopedic practice gives you immediate cash flow, credentialed surgeons, and negotiated payer contracts — but de novo development offers full control and no key-man baggage. Here's how to decide.
The orthopedic sector is one of the most actively consolidated physician specialty verticals in U.S. healthcare, driven by an aging population, rising outpatient procedure volumes, and aggressive private equity roll-up activity. For buyers evaluating entry into this $67 billion market, the core question is whether to acquire an existing clinic with established revenue, payer contracts, and a physician base — or to build a de novo practice from the ground up. Each path carries meaningfully different capital requirements, timelines, regulatory hurdles, and risk profiles. Acquisition offers speed to revenue and immediate EBITDA, but demands rigorous due diligence on physician retention, payer contract transferability, and compliance history. Building from scratch provides structural flexibility and clean-slate culture, but requires 18–36 months before reaching profitability, significant upfront capital for imaging equipment and build-out, and the difficult task of credentialing new physicians across every major payer. This analysis breaks down both paths with orthopedic-specific economics so buyers can make an informed, defensible decision.
Find Orthopedic Clinic Businesses to AcquireAcquiring an established orthopedic clinic delivers immediate access to credentialed surgeons, negotiated payer contracts, an existing patient panel, and proven ancillary revenue streams such as in-house physical therapy, diagnostic imaging, or ASC ownership stakes. At 4–7x EBITDA, acquisition pricing is higher than de novo cost basis in early years, but the risk-adjusted timeline to positive cash flow is dramatically compressed — often from day one post-close.
Private equity-backed physician practice management groups, multi-specialty clinic operators, and individual physicians backed by SBA financing who need a platform with immediate cash flow, an established referral base, and credentialed surgeons ready to operate on day one.
Building a de novo orthopedic clinic offers complete structural control — from physician compensation models and payer strategy to facility design, technology stack, and ancillary service mix. However, the capital outlay is front-loaded and substantial, and the path to profitability requires navigating multi-payer credentialing, recruiting surgeons with an existing referral base, and building brand recognition in a market where established practices benefit from decades of surgeon reputation and hospital relationships.
Individual orthopedic surgeons or small physician groups seeking ownership independence who already have an established patient following, a non-compete expiring from a prior employer, and the financial runway to sustain 18–30 months of negative or breakeven cash flow before scaling.
For most institutional buyers — including PE-backed physician practice management groups, search fund operators, and multi-specialty clinic acquirers — acquiring an established orthopedic clinic is the clearly superior path. The combination of immediate EBITDA, transferable payer contracts, credentialed physicians, and SBA financing availability makes acquisition both faster and more capital-efficient on a risk-adjusted basis. The 4–7x EBITDA acquisition multiple is justified by the 2–3 years of credentialing, recruitment, and brand-building costs avoided. The de novo path makes sense primarily for individual surgeons breaking away from a hospital or group practice with a portable patient panel and a specific vision for practice structure that no existing acquisition target can deliver. If you are evaluating acquisition, concentrate due diligence resources on physician retention mechanics, payer contract transferability, and compliance history — these three factors determine whether an orthopedic acquisition succeeds or destroys value within 24 months of close.
Do you have an existing patient panel, referral network, or surgeon relationships you are bringing to the new entity — or are you starting from zero in the local market?
Can you sustain 18–36 months of negative cash flow during credentialing and ramp-up, or do you need EBITDA from day one to service acquisition debt or satisfy investors?
Is the acquisition target's revenue dependent on one or two surgeons, and have you structured employment agreements, non-competes, and retention incentives sufficient to protect that revenue post-close?
Have you independently verified that all major commercial payer contracts are transferable upon change of ownership, and have you modeled a 90–180 day reimbursement gap scenario in your acquisition pro forma?
Does your target state's corporate practice of medicine law permit your ownership structure, and have you confirmed that a Management Services Organization arrangement or physician-owned entity is properly structured to satisfy Stark Law and anti-kickback requirements?
Browse Orthopedic Clinic Businesses For Sale
Skip the build phase — acquire existing customers, revenue, and cash flow from day one.
Orthopedic clinics in the $1M–$5M revenue range typically trade at 4–7x EBITDA, with higher multiples commanded by practices that have three or more physicians, diversified ancillary revenue streams such as in-house MRI or physical therapy, a high commercial payer mix, and documented EBITDA growth over three or more years. Single-physician practices with heavy Medicare or Medicaid dependence typically trade at the low end of the range, if they attract buyers at all.
Yes. Orthopedic clinic acquisitions are generally SBA 7(a) eligible, allowing qualified buyers to finance 80–90% of the purchase price with a 10-year amortization period. The key requirements include a demonstrated history of clinic profitability, a creditworthy borrower, physician employment agreements in place post-close, and a clean compliance history. Lenders will scrutinize payer contract continuity and physician retention risk as part of underwriting. A seller note of 10–15% is common and often required by SBA lenders as a signal of seller confidence in post-close performance.
Initial credentialing with major commercial payers typically takes 90–180 days per payer, and orthopedic clinics typically need active participation with 8–15 insurance carriers to serve their patient population effectively. Medicare credentialing runs 60–90 days but must be completed before seeing any Medicare beneficiaries. New clinics should budget 12–18 months before achieving full payer participation, and should plan for a period of either out-of-pocket patient arrangements or delayed reimbursement claims during the ramp-up phase.
The five highest-impact due diligence risks in orthopedic clinic acquisitions are: physician key-man concentration — revenue tied to one or two surgeons who could leave post-close; payer contract transferability — some commercial contracts require renegotiation upon ownership change; compliance exposure — undisclosed Stark Law violations, HIPAA breaches, or billing irregularities; referral source concentration — more than 20% of new patient volume from a single referral relationship is a red flag; and real estate entanglement — owned property or above-market leases that complicate deal structure and ongoing overhead.
A Management Services Organization, or MSO, is a legal structure that separates the non-clinical management functions of a medical practice — billing, HR, facilities, technology — from the licensed clinical entity that employs physicians and treats patients. In states with corporate practice of medicine laws that prohibit non-physician entities from owning medical practices, the MSO structure allows PE-backed buyers or non-physician operators to own and profit from the management company while a physician-owned professional corporation retains the clinical license. This structure is common in orthopedic acquisitions involving PE buyers and requires careful legal review to ensure compliance with Stark Law and federal anti-kickback statutes.
The highest-impact pre-sale value drivers for orthopedic clinic owners are: adding a second or third physician to reduce key-man concentration risk; documenting and growing ancillary revenue from physical therapy, diagnostic imaging, or DME; formalizing referral relationships with quantified inbound volume data; producing three years of clean accrual-based financials with physician compensation normalized to market rates; and conducting an internal compliance audit to remediate any Stark Law, HIPAA, or billing issues before a buyer's due diligence team finds them. Practices that address these factors typically command multiples at the high end of the 4–7x range.
More Orthopedic Clinic Guides
Get access to acquisition targets with real revenue, real customers, and real cash flow.
Create your free accountNo credit card required
For Buyers
For Sellers